文献速递艾滋病与性传播感染细菌感染、耐药与抗菌药物

西班牙多中心调查:医生对仿制抗逆转录病毒药与单片方案去简化的看法

Physicians' opinions on generic antiretroviral drugs and single-tablet regimen de-simplification for the treatment of HIV infection: a multicentre survey in Spain.
PubMed 文献 · J Antimicrob Chemother · 2020-01-01

该调查向西班牙HIV/AIDS研究网络(CoRIS)45个中心中199名开具抗逆转录病毒药的医生发放27题在线问卷,169人(84.9%)作答。多数医生愿开具仿制药,但若需增加每日片数或服药次数则多不愿开具;若仿制药需拆分单片方案(STR),医生对依从性下降、不良反应和病毒学失败的担忧明显升高。

要点

  • 仅4.1%医生从不考虑开具仿制抗逆转录病毒药,84.0%在可降低公共医疗成本时同意使用。
  • 若仿制药增加每日片数或服药次数,分别有53.3%和89.3%医生不愿开具。
  • 若仿制药需拆分STR,63.9%担心依从性变差、42.0%担心病毒学失败。

核心结论

  • 多数医生对开具仿制抗逆转录病毒药有信心,但对拆分单片方案(STR)顾虑强烈,并希望获得更多仿制药信息。

研究设计与样本

  • 西班牙HIV/AIDS研究网络(CoRIS)45个中心的多中心调查,向199名开具抗逆转录病毒药的医生发放27题在线问卷,169人(84.9%)作答。

主要发现

  • 仅4.1%医生从不处方仿制抗逆转录病毒药;若每日片数增加53.3%不愿处方,若每日服药次数增加89.3%不愿处方。
  • 84.0%医生同意在降低公共医疗系统成本时使用仿制抗逆转录病毒药。
  • 在每日片数与服药次数不变时,认为仿制药与依从性差、不良反应多、病毒学失败概率高相关的医生分别为0.6%、7.7%、3.6%;若仿制药需拆分STR则分别升至63.9%、18.9%、42.0%。
  • 多数医生表示需要更多关于仿制药有效性、安全性及与品牌药价差的信息。

临床怎么用

  • 处方仿制抗逆转录病毒药时应评估每日片数与服药次数是否增加,避免因拆分STR影响依从性。
  • 对需拆分STR的仿制药替换应充分沟通依从性与病毒学失败风险,并补充仿制药有效性和安全性信息。

局限性

  • 原文摘要未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To assess the attitudes and opinions about generic antiretroviral drugs (ARVs) and single-tablet regimen (STR) de-simplification among physicians prescribing HIV treatment in the cohort of the Spanish HIV/AIDS Research Network (CoRIS). METHODS: An online questionnaire with 27 structured questions was sent to all physicians (n=199) who prescribed ARVs among the 45 centres participating in the cohort. RESULTS: A total of 169 (84.9%) physicians answered the questionnaire. Only 4.1% of the physicians would never prescribe generic ARVs, but 53.3% would not prescribe them if the number of pills per day increased and 89.3% would not prescribe them if the number of doses per day increased. However, 84.0% of the physicians agreed to prescribe generic ARVs if doing so would decrease costs for the public healthcare system. The percentages of physicians stating that generic ARVs (compared with branded ones) would be associated with worse adherence, more adverse effects or more probability of virological failure, provided that the number of pills and doses per day would not change, were low: 0.6%, 7.7% and 3.6%, respectively. However, these percentages were much higher if the generic ARV entailed breaking an STR: 63.9%, 18.9% and 42.0%, respectively. Most physicians stated that they needed more information about the effectiveness and safety of generic ARVs and the price difference compared with their branded equivalents. CONCLUSIONS: Although most physicians were confident about prescribing generic ARVs, the majority had strong concerns about de-simplifying STR, and they also needed more information about generic drugs.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Suárez-García I, Ruiz-Algueró M, García Yubero C, et al. Physicians' opinions on generic antiretroviral drugs and single-tablet regimen de-simplification for the treatment of HIV infection: a multicentre survey in Spain. J Antimicrob Chemother. 2020. PMID: 31665404. doi:10.1093/jac/dkz439

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。